Various Radiopharmaceuticals

The Department of the Army, W40M MRC0 WEST, is soliciting various radiopharmaceuticals under solicitation number W81K0025QA125 to support Brooke Army Medical Center at JBSA Fort Sam Houston, Texas. This requirement is classified under NAICS 325412 Pharmaceutical Preparation Manufacturing and PSC 6505 Drugs and Biologicals. The procurement is conducted with no set-aside (NONE; NONE) and will result in a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity contract. While the initial performance period was established for October 1, 2025, through September 30, 2030, recent amendments have revised the requirement from a five-year to a one-year ordering period.

The scope of work includes the delivery of radiopharmaceuticals such as Ioflupane, with specific delivery timeframes outlined in the updated statement of work. To satisfy a $100.00 minimum guarantee for the contract, the solicitation incorporates CLIN 0011 for a post-award conference. Administrative updates through three amendments have also removed DFARS clause 252.204-7012 and adjusted the performance schedule. Jaclyn Evans is the designated point of contact for this solicitation, which is located in San Antonio, Texas.

Quotes are due by 1600 CST on September 12, 2025. The solicitation includes nine total attachments, featuring several Standard Form 30 amendment documents and a revised Statement of Work posted on September 2, 2025. Other attachments include multiple versions of the solicitation and formal amendment notices released between September 2 and September 11, 2025.